Cyclenium Pharma is currently raising additional financing to further develop their internal programs and expand their proprietary CMRT macrocyclic platform technology.
We will be in attendance at the following events this year:
Redefining Early Stage Investments (RESI) Conference
(April 4, Toronto, Ontario, Canada)
Drug Discovery Chemistry 2017
(April 23-27, San Diego, CA)
International Drug Discovery Science & Technology 2017
(July 25-27, Osaka, Japan)
Discovery on Target 2017
(September 25-29, Boston, MA)
(November 6-8, Berlin, Germany)
Please contact Dr. Helmut Thomas for a complete overview of the opportunities that an investment in Cyclenium Pharma can offer.